Pharmacologic inhibition of Grm3 signaling utilizing two members of a novel class of negative allosteric modulators of Grm3 signaling inhibited self-renewal, GSC marker expression, and in vivo tumor growth in one of two GSC xenograft models. Here, GRM3 is linked to neoplasm.